Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hendriks

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Bioorganic & Medicinal Chemistry|June 29, 2014
Influence of azide incorporation on binding affinity by small papain inhibitorsAngelique E M Wammes, Tom G Hendriks, Helene I V Amatdjais-Groenen, et al.
Clinical Pharmacology and Therapeutics|April 23, 2020
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human HepatocytesDelilah F G Hendriks, Sabine U Vorrink, Tomas Smutny, et al.
Clinical Transplantation|March 15, 2008
The outcome of primary liver transplantation from deceased donors in children with body weight < or =10 kgWojciech G Polak, Paul M J G Peeters, Shungo Miyamoto, et al.
Biotechnology Journal|September 10, 2021
CRISPR-Cas enzymes: The toolkit revolutionizing diagnosticsMatthew S Verosloff, Sarah J Shapiro, Elizabeth M Hawkins, et al.
Journal of Clinical Microbiology|June 29, 2022
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 EnzymeClare L Fasching, Venice Servellita, Bridget McKay, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiationVolker M Lauschke, Sabine U Vorrink, Sabrina M L Moro, et al.
Archives of Toxicology|January 25, 2018
Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigmsChris S Pridgeon, Constanze Schlott, Min Wei Wong, et al.
Scientific Reports|May 5, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseaseCatherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, et al.
ALTEX|June 11, 2020
New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessmentAns Punt, Hans Bouwmeester, Bas J Blaauboer, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Bioorganic & Medicinal Chemistry|June 29, 2014
Influence of azide incorporation on binding affinity by small papain inhibitorsAngelique E M Wammes, Tom G Hendriks, Helene I V Amatdjais-Groenen, et al.
Clinical Pharmacology and Therapeutics|April 23, 2020
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human HepatocytesDelilah F G Hendriks, Sabine U Vorrink, Tomas Smutny, et al.
Clinical Transplantation|March 15, 2008
The outcome of primary liver transplantation from deceased donors in children with body weight < or =10 kgWojciech G Polak, Paul M J G Peeters, Shungo Miyamoto, et al.
Biotechnology Journal|September 10, 2021
CRISPR-Cas enzymes: The toolkit revolutionizing diagnosticsMatthew S Verosloff, Sarah J Shapiro, Elizabeth M Hawkins, et al.
Journal of Clinical Microbiology|June 29, 2022
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 EnzymeClare L Fasching, Venice Servellita, Bridget McKay, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiationVolker M Lauschke, Sabine U Vorrink, Sabrina M L Moro, et al.
Archives of Toxicology|January 25, 2018
Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigmsChris S Pridgeon, Constanze Schlott, Min Wei Wong, et al.
Scientific Reports|May 5, 2016
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseaseCatherine C Bell, Delilah F G Hendriks, Sabrina M L Moro, et al.
ALTEX|June 11, 2020
New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessmentAns Punt, Hans Bouwmeester, Bas J Blaauboer, et al.
Pageof 9